Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1991 Feb 1;273(Pt 3):533–539. doi: 10.1042/bj2730533

'Slow-binding' sixth-ligand inhibitors of cytochrome P-450 aromatase. Studies with 19-thiomethyl- and 19-azido-androstenedione.

J N Wright 1, G Slatcher 1, M Akhtar 1
PMCID: PMC1149795  PMID: 1996954

Abstract

The progress curves for the inhibition of aromatase by 19-thiomethylandrostenedione and 19-azidoandrostenedione were found to be non-linear where the extent of inhibition increased with time. Further experiments enabled these compounds to be classified as 'slow-binding' inhibitors of aromatase. The phenomenon was attributed to the formation of an initial E.I complex that rearranged to another species (E.I*) in which the interaction between the enzyme and inhibitor had been maximized, giving rise to tighter binding. When 19-thiomethylandrostenedione was used as the inhibitor the t0.5 (half-time) for the dissociation of E.I* was calculated to be 12.6 min with Ki and Ki* values of 2.4 and 1.4 nM respectively. In the case of 19-azidoandrostenedione, the two separate dissociation constants were not determined, and a single Ki value of 5 nM was obtained. The conclusions drawn from kinetic studies were confirmed by absorption spectrometry, when time-dependent formation of complexes between aromatase and either 19-thiomethylandrostenedione or 19-azidoandrostenedione were observed by the formation of 'Type II' spectra. The two complexes respectively had maxima at 429 and 418 nm. The spectral data suggested that the two inhibitors interact with the haem iron of aromatase, forming hexaco-ordinated species for which structural models are presented.

Full text

PDF
533

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akhtar M., Calder M. R., Corina D. L., Wright J. N. Mechanistic studies on C-19 demethylation in oestrogen biosynthesis. Biochem J. 1982 Mar 1;201(3):569–580. doi: 10.1042/bj2010569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bednarski P. J., Nelson S. D. Interactions of thiol-containing androgens with human placental aromatase. J Med Chem. 1989 Jan;32(1):203–213. doi: 10.1021/jm00121a037. [DOI] [PubMed] [Google Scholar]
  3. Cole P. A., Bean J. M., Robinson C. H. Conversion of a 3-desoxysteroid to 3-desoxyestrogen by human placental aromatase. Proc Natl Acad Sci U S A. 1990 Apr;87(8):2999–3003. doi: 10.1073/pnas.87.8.2999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cole P. A., Robinson C. H. Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem. 1990 Nov;33(11):2933–2942. doi: 10.1021/jm00173a001. [DOI] [PubMed] [Google Scholar]
  5. DIXON M. The determination of enzyme inhibitor constants. Biochem J. 1953 Aug;55(1):170–171. doi: 10.1042/bj0550170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harada N. Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase. J Biochem. 1988 Jan;103(1):106–113. doi: 10.1093/oxfordjournals.jbchem.a122213. [DOI] [PubMed] [Google Scholar]
  7. Jefcoate C. R. Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy. Methods Enzymol. 1978;52:258–279. doi: 10.1016/s0076-6879(78)52029-6. [DOI] [PubMed] [Google Scholar]
  8. Kellis J. T., Jr, Childers W. E., Robinson C. H., Vickery L. E. Inhibition of aromatase cytochrome P-450 by 10-oxirane and 10-thiirane substituted androgens. Implications for the structure of the active site. J Biol Chem. 1987 Mar 25;262(9):4421–4426. [PubMed] [Google Scholar]
  9. Kellis J. T., Jr, Vickery L. E. Purification and characterization of human placental aromatase cytochrome P-450. J Biol Chem. 1987 Mar 25;262(9):4413–4420. [PubMed] [Google Scholar]
  10. Morrison J. F., Walsh C. T. The behavior and significance of slow-binding enzyme inhibitors. Adv Enzymol Relat Areas Mol Biol. 1988;61:201–301. doi: 10.1002/9780470123072.ch5. [DOI] [PubMed] [Google Scholar]
  11. Nastainzcyk W., Ruf H. H., Ullrich V. Ligand binding of organic sulfides to microsomal cytochrome P-450. Eur J Biochem. 1975 Dec 15;60(2):615–620. doi: 10.1111/j.1432-1033.1975.tb21039.x. [DOI] [PubMed] [Google Scholar]
  12. Osawa Y., Shibata K., Rohrer D., Weeks C., Duax W. L. Letter: Reassignment of the absolute configuration of 19-substituted 19-hydroxysteroids and stereomechanism of estrogen biosynthesis. J Am Chem Soc. 1975 Jul 23;97(15):4400–4402. doi: 10.1021/ja00848a046. [DOI] [PubMed] [Google Scholar]
  13. RYAN K. J. Biological aromatization of steroids. J Biol Chem. 1959 Feb;234(2):268–272. [PubMed] [Google Scholar]
  14. Skinner S. J., Akhtar M. The stereospecific removal of a C-19 hydrogen atom in oestrogen biosynthesis. Biochem J. 1969 Aug;114(1):75–81. doi: 10.1042/bj1140075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Thompson E. A., Jr, Siiteri P. K. The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem. 1974 Sep 10;249(17):5373–5378. [PubMed] [Google Scholar]
  16. Williams J. W., Morrison J. F. The kinetics of reversible tight-binding inhibition. Methods Enzymol. 1979;63:437–467. doi: 10.1016/0076-6879(79)63019-7. [DOI] [PubMed] [Google Scholar]
  17. Wright J. N., Akhtar M. Studies on estrogen biosynthesis using radioactive and stable isotopes. Steroids. 1990 Apr;55(4):142–151. doi: 10.1016/0039-128x(90)90102-h. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES